Contents
Tadalafil is a drug used to treat erectile dysfunction, benign enlargement of the prostate and pulmonary hypertension.
Advertisement
Basics
Tadalafil is a vasodilator and blood pressure-lowering phosphodiesterase-5 inhibitor and is used to treat erectile dysfunction, benign enlargement of the prostate, and pulmonary hypertension. Unlike other similarly acting drugs such as sildenafil (Viagra), tadalafil has a better and longer-lasting effect and is more suitable for daily dosing.
Pharmacology
Pharmacodynamics
Tadalafil inhibits the enzyme phosphodiesterase-5, which delays the breakdown of the neurotransmitter cGMP. This triggers a relaxation of the smooth muscle in the penis, causing the blood vessels to dilate and allowing more blood to flow into the corpus cavernosum. As a result, an erection can be produced or maintained longer and stronger.
The drug also causes the smooth muscle of the pulmonary vessels to relax, lowering blood pressure in the pulmonary arteries.
In benign enlargement of the prostate, tadalafil reduces smooth muscle cell growth, helping to reduce prostate size and relieve symptoms.
Pharmacokinetics
The maximum plasma concentration of tadalafil is reached after approximately 2 hours and is 94% bound to plasma proteins. The half-life is 15-17.5 hours. In the liver, the drug is metabolized by the enzyme CYP3A4 and excreted mainly in the stool and 30% in the urine.
Drug Interactions
Since tadalafil enhances the antihypertensive effect of nitrates, NO donors, amyl nitrite, and other antihypertensive agents, the agents should not be used concomitantly. Interactions may also occur with drugs that are also degraded by CYP3A4.
Toxicity
Side effects
Possible side effects include headache, dizziness, dyspepsia (upper abdominal discomfort), back pain, infection of the pharyngeal mucosa, and facial flushing, as well as low blood pressure and visual disturbances.
Toxicological data
Symptoms of overdose are similar to typical side effects.

Author
Markus Falkenstätter, BSc
Pharmacy student
Markus Falkenstätter is a writer on pharmaceutical topics in Medikamio's medical editorial team. He is in the last semester of his pharmacy studies at the University of Vienna and loves scientific work in the field of natural sciences.

Reviewer
Mag. pharm. Stefanie Brandauer
Pharmacist
Stefanie Lehenauer has been a freelance writer for Medikamio since 2020 and studied pharmacy at the University of Vienna. She works as a pharmacist in Vienna and her passion is herbal medicines and their effects.
Editorial principles
All information used for our content comes from verified sources (recognised institutions, specialists, studies by renowned universities). We place great value on the qualification of the authors and the scientific background of the information, so that our research is based on scientific evidence.